发明公开
EP2399934A1 NOVEL MONOCLONAL ANTIBODY, AND USE THEREOF 有权
维也纳戴蒙公司的诺基亚MONOKLONALERANTIKÖRPER

NOVEL MONOCLONAL ANTIBODY, AND USE THEREOF
摘要:
[Theme] To provide a monoclonal antibody against human GPR87. Also, to provide a novel means for diagnosing or treating a malignant tumor.
[Solution means] Monoclonal antibodies against human GPR87 are provided. The antibodies can recognize human GPR87, which is expressed on a cell membrane while retaining a three-dimensional structure, and can recognize GPR87, which is expressed in a cell endogenously with an epitope being present in an extracellular domain of full-length human GPR87. The antibodies are thus useful in biochemical analysis, etc., of GPR87, useful in immunohistological diagnosis, etc., of squamous cell carcinoma, and also potentially useful in PET diagnosis, antibodies for treatment, etc., of squamous cell carcinoma.
公开/授权文献
信息查询
0/0